SEHNERT, Bettina, BURKHARDT, Harald, DÜBEL, Stefan und VOLL, Reinhard, 2020. Cell-type targeted NF-kappa B inhibition for the treatment of inflammatory diseases. Freiburg: Universität.
Elsevier - Harvard (with titles)Sehnert, B., Burkhardt, H., Dübel, S., Voll, R., 2020. Cell-type targeted NF-kappa B inhibition for the treatment of inflammatory diseases. Universität, Freiburg. https://doi.org/10.3390/cells9071627
American Psychological Association 7th editionSehnert, B., Burkhardt, H., Dübel, S., & Voll, R. (ca. 2020). Cell-type targeted NF-kappa B inhibition for the treatment of inflammatory diseases [Cd]. Universität. https://doi.org/10.3390/cells9071627
Springer - Basic (author-date)Sehnert B, Burkhardt H, Dübel S, Voll R (2020) Cell-type targeted NF-kappa B inhibition for the treatment of inflammatory diseases. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Sehnert, Bettina/ Burkhardt, Harald/ Dübel, Stefan/ Voll, Reinhard, Cell-type targeted NF-kappa B inhibition for the treatment of inflammatory diseases, Freiburg 2020.